Gynecologic Oncology Research

Behbakht, K., Sill, M. W., Darcy, K. M., Rubin, S. C., Mannel, R. S., Waggoner, S., et al. (2011). Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A gynecologic oncology group study. Gynecologic Oncology, 123 (1)., 19-26

URL: http://www.ncbi.nlm.nih.gov/pubmed/21752435

DOI: http://dx.doi.org/10.1016/j.ygyno.2011.06.022 or

http://www.sciencedirect.com/science/article/pii/S0090825811004896

Cohn, D. E., Kim, K. H., Resnick, K. E. , O'Malley, D. M., & Straughn, J. M.,Jr. (2011). At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 29 (10)., 1247-1251

URL: http://www.ncbi.nlm.nih.gov/pubmed/21383297

DOI: http://dx.doi.org/10.1200/JCO.2010.32.1075 or

http://jco.ascopubs.org/content/29/10/1247

Debernardo, R. , Starks, D., Barker, N., Armstrong, A., & Kunos, C. A. Robotic surgery in gynecologic oncology. (2011). Obstetrics and Gynecology International, 2011, 139867

URL: http://www.ncbi.nlm.nih.gov/pubmed/22190946

PMC Full-text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236394/

DOI: http://dx.doi.org/10.1155/2011/139867 or

http://www.hindawi.com/journals/ogi/2011/139867/ (open access)

Additional Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236394/pdf/OGI2011-139867.pdf

Dizon, D. S., Sill, M. W., Gould, N., Rubin, S. C., Yamada, S. D., Debernardo, R. L. , et al. (2011). Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study. Gynecologic Oncology, 123 (2)., 182-186

URL: http://www.ncbi.nlm.nih.gov/pubmed/21820161

DOI: http://dx.doi.org/10.1016/j.ygyno.2011.07.016 or

http://www.sciencedirect.com/science/article/pii/S009082581100566X

Gunderson, C. C., Knight, J., Ybanez-Morano, J., Ritter, C., Escobar, P. F., Ibeanu, O., et al. (2012). The risk of umbilical hernia and other complications with laparoendoscopic single-site surgery. Journal of Minimally Invasive Gynecology, 19 (1)., 40-45

URL: http://www.ncbi.nlm.nih.gov/pubmed/22033285

DOI: https://doi.org/10.1016/j.jmig.2011.09.002 or

http://www.sciencedirect.com/science/article/pii/S1553465011011861

Huang, M. I., Debernardo, R. L. , Rodgers, M., & Hart, D. J. (2011). Endometrial stromal sarcoma metastasis to the lumbar spine and sphenoid bone. Rare Tumors, 3 (3)., e27

URL: http://www.ncbi.nlm.nih.gov/pubmed/21370596

DOI: http://dx.doi.org/10.4081/rt.2011.e27 or

http://www.pagepress.org/journals/index.php/rt/article/view/2709

Kunos, C., Woods, C., Colussi, V. C., Abdul-Karim, F. W., & Waggoner, S. (2011). Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 29 (5)., e104-6

URL: http://www.ncbi.nlm.nih.gov/pubmed/21098325

DOI: http://dx.doi.org/10.1200/JCO.2010.31.7545 or

http://jco.ascopubs.org/content/29/5/e104

Kunos, C. A., Sill, M. W., Buekers, T. E., Walker, J. L., Schilder, J. M., Yamada, S. D., et al. (2011). Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the gynecologic oncology group. Gynecologic Oncology, 120 (2)., 224-228

URL: http://www.ncbi.nlm.nih.gov/pubmed/21075438

PMC Full-text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026069

DOI: http://dx.doi.org/10.1016/j.ygyno.2010.10.018 or

http://www.sciencedirect.com/science/article/pii/S009082581000764X

Additional Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026069/pdf/nihms253500.pdf

Liu, J. H. , & Zanotti, K. M. (2011). Management of the adnexal mass. Obstetrics and Gynecology, 117 (6)., 1413-1428

URL: http://www.ncbi.nlm.nih.gov/pubmed/21606754

DOI: http://dx.doi.org/10.1097/AOG.0b013e31821c62b6 or

http://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=2011&issue=06000&article=00023&type=abstract

Morgan, M. A., Sill, M. W., Fujiwara, K., Greer, B., Rubin, S. C., Degeest, K., et al. (2011). A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study. Gynecologic Oncology, 121 (2)., 264-268

URL: http://www.ncbi.nlm.nih.gov/pubmed/21277623

DOI: http://dx.doi.org/10.1016/j.ygyno.2010.12.358 or

http://www.sciencedirect.com/science/article/pii/S0090825810012655

Resnick, K. E. , Frankel, W. L., Morrison, C. D., Fowler, J. M., Copeland, L. J., Stephens, J., et al. (2010). Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecologic Oncology, 117 (2)., 234-238

URL: http://www.ncbi.nlm.nih.gov/pubmed/20153885

DOI: http://dx.doi.org/10.1016/j.ygyno.2009.12.028 or

http://www.sciencedirect.com/science/article/pii/S009082581000003X

Sandadi, S., Frasure, H. E., Broderick, M. J., Waggoner, S. E. , Miller, J. A., & von Gruenigen, V. E. (2011). The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecologic Oncology, 123 (2)., 351-355

URL: http://www.ncbi.nlm.nih.gov/pubmed/21855973

DOI: http://dx.doi.org/10.1016/j.ygyno.2011.07.028 or

http://www.sciencedirect.com/science/article/pii/S0090825811005786

von Gruenigen, V., Frasure, H., Fusco, N., DeBernardo, R., Eldermire, E., Eaton, S., et al. (2010). A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients. Cancer, 116 (20)., 4735-4743

URL: http://www.ncbi.nlm.nih.gov/pubmed/20629022

DOI: http://dx.doi.org/10.1002/cncr.25262 or

http://onlinelibrary.wiley.com/doi/10.1002/cncr.25262/abstract

Additional Link: http://onlinelibrary.wiley.com/doi/10.1002/cncr.25262/pdf

von Gruenigen, V. E. , Frasure, H. E., Kavanagh, M. B., Lerner, E., Waggoner, S. E. , & Courneya, K. S. (2011). Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecologic Oncology, 122 (2)., 328-333

URL: http://www.ncbi.nlm.nih.gov/pubmed/21600635

DOI: http://dx.doi.org/10.1016/j.ygyno.2011.04.043 or

http://www.sciencedirect.com/science/article/pii/S0090825811003441

von Gruenigen, V. E., Waggoner, S. E. , Frasure, H. E., Kavanagh, M. B., Janata, J. W. , Rose, P. G., et al. (2011). Lifestyle challenges in endometrial cancer survivorship. Obstetrics and Gynecology, 117(1). , 93-100

URL: http://www.ncbi.nlm.nih.gov/pubmed/21173649

DOI: http://dx.doi.org/10.1097/AOG.0b013e31820205b3 or

http://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=2011&issue=01000&article=00014&type=abstract

Make an Appointment

Schedule your appointment with a specialist at University Hospitals.
1-866-UH4-CARE (1-866-844-2273)

More Scheduling Options

Need to Refer a Patient?

Click here for Patient Referrals

Better Living Blog

How much protein is enough? Should you strength train as you age? How to fight fatigue? The answer to these questions and many others are contained in our monthly "Better Living" blog. For a FREE subscription, visit our Sign Up page.

Sign Up Now

Browse Services A-Z

Maps and Directions

Click here for directions